MOH

SEC source: 0001856013-26-000002 · wk-form4_1767390888.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,742

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

SEC source: 0001206684-26-000002 · wk-form4_1767390845.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,733

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001211493-26-000002 · wk-form4_1767390926.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,325

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001649773-26-000002 · wk-form4_1767390810.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,669

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

SEC source: 0001263714-26-000002 · wk-form4_1767390758.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 7,947

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001257996-26-000002 · wk-form4_1767390711.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

SEC source: 0001228861-26-000002 · wk-form4_1767390671.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 14,991

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025.

F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

SEC source: 0002010075-26-000002 · wk-form4_1767390507.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,906

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP provisions, the purchase price of $147.51 is 85% of $173.54 which was the closing price of the Issuer's common stock on December 31, 2025, the last trading day of the ESPP offering period. The purchase price is based on the lower market price as of the two following dates: (i) July 1, 2025, the first day of the ESPP offering period, and (ii) December 31, 2025, the last day of the ESPP offering period.

F3 · balance_after: The shares vest as follows: 2,021 shares on March 1, 2026; 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 shares on March 1, 2028. The remaining shares are vested.

SEC source: 0001649773-25-000007 · wk-form4_1764020115.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,352

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $143.00 to $143.18. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001169490-25-000005 · wk-form4_1759449625.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,859

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

SEC source: 0001263714-25-000006 · wk-form4_1759450131.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 7,630

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001228861-25-000005 · wk-form4_1759450080.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 14,674

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

SEC source: 0001649773-25-000006 · wk-form4_1759449946.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,709

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

SEC source: 0001206684-25-000008 · wk-form4_1759449892.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,416

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001211493-25-000003 · wk-form4_1759449811.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,008

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001257996-25-000003 · wk-form4_1759449680.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 583

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

SEC source: 0001856013-25-000003 · wk-form4_1759449736.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,425

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares.

F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025.

SEC source: 0001179929-25-000123 · wk-form4_1754685290.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,131

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $153.43 to $154.32. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001179929-25-000121 · wk-form4_1754513252.xml · nonDerivative · entry 2

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,331

F2 · price: Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $156.01 to $156.94. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.

F3 · balance_after: The shares vest as follows: 5,337 shares on March 1, 2026; 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.

SEC source: 0001179929-25-000121 · wk-form4_1754513252.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,831

F1 · price: Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $155.00 to $155.98. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.

SEC source: 0001179929-25-000105 · wk-form4_1751490935.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,574

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

SEC source: 0001179929-25-000112 · wk-form4_1751491331.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 7,345

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001179929-25-000110 · wk-form4_1751491223.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,424

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

SEC source: 0001179929-25-000111 · wk-form4_1751491273.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 14,389

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

SEC source: 0001179929-25-000109 · wk-form4_1751491159.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,831

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001179929-25-000108 · wk-form4_1751491103.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 16,723

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001179929-25-000107 · wk-form4_1751491054.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,140

F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

SEC source: 0001179929-25-000104 · wk-form4_1751490874.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,884

F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 530 shares on July 1, 2025.

F4 · balance_after: The shares vest as follows: 2,021 shares on March 1, 2026; 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 shares on March 1, 2028. The remaining shares are vested.

SEC source: 0001179929-25-000106 · wk-form4_1751490991.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298

F1 · kind: Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025.

SEC source: 0001179929-25-000113 · wk-form4_1751491368.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,331

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2025 of $291.05 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2025, the first date of the ESPP offering period, and (ii) June 30, 2025, the last trading day of the offering period).

F3 · balance_after: The shares vest as follows: 5,337 shares on March 1, 2026; 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.

SEC source: 0001179929-25-000104 · wk-form4_1751490874.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,067

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2025 of $291.05 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2025, the first date of the ESPP offering period, and (ii) June 30, 2025, the last trading day of the offering period).

SEC source: 0001179929-25-000103 · wk-form4_1751490817.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,902

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP, the purchase price is 85% of the closing price of the Issuer's common stock on January 1, 2025 of $291.05 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2025, the first date of the ESPP offering period, and (ii) June 30, 2025, the last trading day of the offering period).

F3 · balance_after: The shares vest as follows: 4,183 shares on March 1, 2026; 2,722 shares on March 1, 2027; and 1,619 shares on March 1, 2028. The remaining shares are vested.

SEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 4

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 14,209

F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $324.42 to $324.45. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting.

SEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 3

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 14,309

F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $322.93 to $323.68. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting.

SEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 2

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 15,209

F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $321.90 to $322.62. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting.

SEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 15,609

F1 · price: Represents the selling price per share of all 100 shares.

F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting.

SEC source: 0001179929-25-000087 · wk-form4_1746477400.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 16,543

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $318.00 to $318.78. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001179929-25-000085 · wk-form4_1746218625.xml · nonDerivative · entry 1

GROHOWSKI LEO P · CIK 0001257996 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118

F1 · kind: Grant of stock under the Issuer's 2025 Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: Represents the prorated quarterly director grant. Mr. Grohowski was elected as a director on April 30, 2025.

F3 · price: Represents the closing price of the Issuer's common stock on May 1, 2025.

SEC source: 0001179929-25-000081 · wk-form4_1746218084.xml · nonDerivative · entry 2

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 257,715

F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $324.22 to $324.84. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee.

SEC source: 0001179929-25-000081 · wk-form4_1746218084.xml · nonDerivative · entry 1

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Trust

Disclosed balance after: 258,815

F1 · shares: The reported securities were sold in a block sale at a per share price of $320.00.

F2 · ownership.nature: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee.

SEC source: 0001179929-25-000079 · wk-form4_1746132058.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,244

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $320.46 to $320.50. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

SEC source: 0001179929-25-000057 · wk-form4_1743627093.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,394

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

SEC source: 0001179929-25-000064 · wk-form4_1743627704.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 7,165

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

SEC source: 0001179929-25-000062 · wk-form4_1743627538.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,913

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

SEC source: 0001179929-25-000063 · wk-form4_1743627646.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,709

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

SEC source: 0001179929-25-000061 · wk-form4_1743627437.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,651

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

SEC source: 0001179929-25-000060 · wk-form4_1743627358.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,543

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

SEC source: 0001179929-25-000059 · wk-form4_1743627235.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,960

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

SEC source: 0001179929-25-000058 · wk-form4_1743627181.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,383

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since Mr. Cooperman will not be seeking re-election at the 2025 annual stockholders' meeting, the value of his grant was prorated for one month to $18,333. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 56 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025.

SEC source: 0001179929-25-000031 · wk-form4_1741137408.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,375

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $301.31 to $301.51. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

F2 · ownership.nature: Shares are held by Orlando Family Trust.